ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis

Liu, Di; Xu, Wei Pan; Xu, Hang; Zhao, Lin*; Jin, Dao Qun*polytech univ; wuhan univ sci & technol
Frontiers in Cardiovascular Medicine2023-10-17DOI: 10.3389/fcvm.2023.1265983
23阅读
引用收藏
分享

摘要

BackgroundThe benefits and risks of aspirin verse clopidogrel monotherapy in patients with coronary artery disease (CAD) remain controversial. This meta-analysis evaluated the efficacy and safety of aspirin verse clopidogrel monotherapy for long-term treatment in patients with CAD.MethodsLiterature was searched in the Pubmed, the Cochrane Library, and the Embase databases until March 2023. The Cochrane Risk of Bias Tool was used to assess the risk of bias in included studies. Data were extracted from the included studies, heterogeneity analysis, and pooled analysis conducted by RevMan 5.3 software.ResultsA total of five trials were included, involving 11, 766 patients with CAD. Compared with the aspirin group, the clopidogrel group was associated with reduced risk of major adverse cardiac and cerebrovascular events (MACCE) [risk ratio (RR) = 0.68, P = 0.0007], myocardial infarction (MI, RR = 0.66, P = 0.01), stroke (RR = 0.58, P = 0.003), and BARC major bleeding (RR = 0.63, P = 0.02). There were no significant differences in death from any cause (RR = 1.06, P = 0.59) and vascular death (RR = 0.92, P = 0.62) between the two groups.ConclusionsPatients with CAD use clopidogrel could further reduce the risk of MACCE, MI, stroke, and BARC major bleeding, compared with the use of aspirin. This finding supported the use of clopidogrel rather than aspirin in patients with CAD who required long-term antiplatelet monotherapy for preventing ischemic events.

学科与关键词

关键词
coronary artery diseaseantiplatelet monotherapyaspirinclopidogrelefficacysafety
相关
加载中…
  • Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study)
    He, Meijiao; Yan, Wei; Zhang, Yun; Kong, Yihui; Han, Xuejie; Ren, Jie; Zhao, Zhongyang; Liu, Guangzhong; Shi, Jing*; Li, Yue*Platelets, 2022, 33(8): 1146-1152.被引 2
  • The Effect of Aspirin on the Primary Prevention of Major Adverse Cardiac and Cerebrovascular Events in Chinese Older Adults: A Registration Study
    Sun, Xiaojia*; Sun, Ruihong; Zhang, LimingDrugs and Aging, 2022, 39(1): 97-106.
  • 替格瑞洛与氯吡格雷用于急性冠状动脉综合征疗效及安全性比较的Meta分析
    何芸; 王淑香; 赵强; 吴同果白求恩医学杂志, 2015, (04): 354-356.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cardiovascular Medicine
发表日期
2023-10-17
卷期
第 10 卷
页码
1265983
DOI
10.3389/fcvm.2023.1265983
成果收录
SCIE
资助标注
This research was funded by Research project of Natural Science Foundation of Hubei Province, grant number 2022CFB159; Foundation of Health Commission of Hubei Province, grant number WJ2023F061; Hubei Polytechnic University, grant number 22xjz06Q. [2022CFB159]; Research project of Natural Science Foundation of Hubei Province [WJ2023F061]; Foundation of Health Commission of Hubei Province [22xjz06Q]; Hubei Polytechnic University

作者

  • L

    Liu, Di (第一作者)

    polytech univ

  • X

    Xu, Wei Pan

    wuhan univ sci & technol · polytech univ

查看全部 5 位作者收起作者
  • X

    Xu, Hang

    wuhan univ sci & technol · polytech univ

  • Z

    Zhao, Lin (通讯)

    polytech univ

  • J

    Jin, Dao Qun (通讯)

    polytech univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417